NCT05362708

Brief Summary

Hypnosis and virtual reality are potential tools for treating acute. Nevertheless, the neurophysiological correlates of such tools used together, i.e. 'virtual reality hypnosis' (VRH) (Patterson et al., 2004) remain mostly understudied. This study aims to improve our knowledge and understanding of the dissociation (i.e., a mental separation of components of behaviours that normally would be processed together) occurring during VRH. This is a clinical trial aiming at understanding if the VRH reduces pain during a port-a-cath intervention in oncological patients and if dissociation may explain the pain alteration.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started May 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 5, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

May 5, 2022

Status Verified

May 1, 2022

Enrollment Period

11 months

First QC Date

April 13, 2022

Last Update Submit

May 4, 2022

Conditions

Keywords

Virtual RealityHypnosisDissociation

Outcome Measures

Primary Outcomes (2)

  • Dissociation state

    Corresponds to a dissociation between the bodily sensations and the actual environment that one feels in a particular situation. will be assessed with a numerical rating scale (0= no dissociation; 10 = dissociation from environment).

    During the procedure

  • Pain intensity

    The amount of pain one experiences in a particular situation. Will be assessed with a visual analogy scale, 0= no pain at all; 10= worst pain imaginable.

    During the procedure

Secondary Outcomes (14)

  • Dissociation trait

    During the procedure

  • Hypnotisability

    During the procedure

  • Absorption trait

    During the procedure

  • Anxiety trait

    During the procedure

  • Immersion propensity (trait)

    During the procedure

  • +9 more secondary outcomes

Study Arms (2)

Experimental group - VRH

EXPERIMENTAL

Patients will receive VRH during port-a-cath (Port) placement

Device: Clinical - Hypnosis with VR (VRH)

Control Group

NO INTERVENTION

Patients who do not want to receive the VRH but who accept to answer the questionnaires will be considered as a control group.

Interventions

The VRH intervention will use the Aqua video session developed by Oncomfort during a port-a-cath procedure.

Experimental group - VRH

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Low auditory and/or visual acuity precludes the use of the device.
  • Head or face wounds precluding the use of the device.
  • Schizophrenia, dissociative disorder or any other psychiatric disorder.
  • Non-proficiency in French (Research language).
  • Patient under 18 years old.
  • Phobia of deep water.
  • Allergy to cutaneous electrodes.
  • Chronic pain and/or chronic analgesics consumption.
  • Medication affecting the autonomic nervous system.
  • Dizziness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

NeoplasmsDissociative Disorders

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Audrey ANHAUDENHUYSE, PhD

    CHU of Liège

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aminata Bicego, PhD

CONTACT

Rodrigo Montenegro, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
Methodology of virtual reality hypnosis prevents masking participants and experimenter.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients who are not interested will be considered as a control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, head of the Perception and Sensation Research Group - GIGA Consciousness

Study Record Dates

First Submitted

April 13, 2022

First Posted

May 5, 2022

Study Start

May 1, 2022

Primary Completion

April 1, 2023

Study Completion

October 1, 2023

Last Updated

May 5, 2022

Record last verified: 2022-05